Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.01, read 2026-10-24
Ethical does not pass the values gate
Price36.75 USD
Fair value22.51
Ethical score70.0/100
Our investment reviews on this name
2026-09-16Read Accumulation28.26+30.0% to today ✓Markup gives way to Accumulation after a 13% rise in 4 weeks
2026-08-16Read Markup25.05+46.7% to today ✓Distribution gives way to Markup after a 66% rise in 6 weeks
2026-07-02Read Distribution15.10+143.4% to today First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Via Transportation, Inc. holds its Accumulation at $36.75. The statistical read favours the sellers, held for 51 days.
As held on the ledger · 2026-10-23
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 51 days
Price at the screen
$36.75
Valuation
N/A trailing · 92.68 forward price to earnings
Values screen
FAIL· score 70.0
The Workings
Five Screens, Shown in Full
Does not pass. Accounts receivable
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
2.61%
Below 33%
Interest-bearing debt is just 2.6% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
61.72%
Below 49%
Money owed to the company is 61.7% of assets, above the 49% limit.
Fail
Revenue purity
1.21%
Below 5%
Only 1.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Via Transportation,'s business is fine, but its receivables are about 62% of its assets, well over the ~49% line, so it does not pass on the financial screens.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when VIA's ethical verdict changes
Today VIA does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. The price runs 38.8% above the base estimate.
Third-party analyst targets: 9 covering, consensus Strong Buy. The average target sits −5% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Transit platform still burning cash at a premium
Picture a city bus network that books rides like an app but still loses money on every journey. Via Transportation supplies the software layer that digitises public transit, yet the numbers show revenue growing 29 percent while margins sit at minus 22 percent and return on equity is minus 24 percent. The shares trade at 32 times forward earnings with no proven moat and an opportunity rating of none, so we pass despite an ethical screen that clears.
Fair value sits only 10 percent above the current price of 17.96 dollars, offering little cushion once losses are factored in. Nine analysts see a median target of 25 dollars, but that optimism rests on growth that has yet to reach the bottom line. Unknown competitive defences and continued negative profitability leave little room for error in execution.
Currency moves, contract delays and the need to keep spending to win new networks add real downside. The ethical verdict is clean, yet the financial profile does not meet our bar. Analysis, not advice.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
VIA trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-25Accumulation$35.71+13.9%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 13.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (10 analysts) rates it none, with a mean price target of $31.
2026-10-18Accumulation$31.35+12.0%Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 12.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (10 analysts) rates it none, with a mean price target of $31.
2026-10-02Accumulation$27.98-1.0%Entry 6
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (10 analysts) rates it none, with a mean price target of $31.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 12.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (10 analysts) rates it none, with a mean price target of $31.
2026-08-16Markup · changed$25.05+65.9%Entry 4
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 65.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (10 analysts) rates it none, with a mean price target of $31.
2026-07-18Distribution$15.10+0.0%Entry 3
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (10 analysts) rates it none, with a mean price target of $31.
2026-07-03Distribution$15.10+0.0%Entry 2
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Distribution$15.10Entry 1
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
